The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows.Patients taking semag ...

Eli Lilly & Co. (NYSE:LLY) plans to start selling its popular weight-loss medication, Mounjaro, in Hong Kong by the end of ...

Learn how to grow your wealth through smart investing strategies and financial planning in this informative article by a ...

This report summarizes recent health news, covering Eli Lilly's Hong Kong approval for its weight-loss drug, a McDonald's E.

Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits ...

Lizzo is getting in on the joke with a new Halloween costume that spoofs a bit from South Park: The End of Obesity, a TV special of the animated Comedy Central sitcom that referenced the musician and ...

Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity ...

City employees in NYC had insurance coverage for GLP-1 drugs like Wegovy and Zepbound for less than a year before learning it ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Semaglutide, the active ingredient in Ozempic and Wegovy, may lower the risk of Alzheimer’s disease.A new study suggests type 2 diabetes patients taking semaglu ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...